Skip to main content
. 2022 Nov;11(11):2289–2305. doi: 10.21037/tlcr-22-732

Figure 2.

Figure 2

Flowchart of patients with immune checkpoint inhibitor rechallenge who developed CIP recurrence and their outcomes. CIP, checkpoint inhibitor-related pneumonitis.